---
layout: post
title:  "NOX-E36 L-aptamer"
date:   2024-05-05 00:00:00
author: Yuxuan Sun, Baowei Huang
categories: Aptamer
---
<html>
<head>
  <title>横向排列的点击按钮</title>
  <style>
    /* 按钮容器样式 */
    .button-container {
      display: flex;
      justify-content: left;
      align-items: center;
      height: 50px;
    }
    /* 按钮样式 */
    .button {
      display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: center;
      background-color: #ffffff;
      color: #520049;
      text-decoration: none;
      border: 1px solid #520049;
      border-radius: 5px;
    }
    /* 鼠标悬停样式 */
    .button:hover {
      background-color: #c9c5c5;
      cursor: pointer;
    }
  </style>
</head>
<!--body>
  <p style="font-size: 16px">Click the buttons to navigate to different sections:</p>
  <div class="button-container">
    <a class="button" style="color:#520049" href="#timeline">Timeline</a>
    <a class="button" style="color:#520049" href="#description">Description</a>
    <a class="button" style="color:#520049" href="#SELEX">SELEX</a>
    <a class="button" style="color:#520049" href="#structure">Structure</a>
    <a class="button" style="color:#520049" href="#ligand-recognition">Ligand recognition
    <a class="button" style="color:#520049" href="#references">References</a>
   </a>
  </div>
</body-->
</html>

<html lang="zh-cn">
<head>
<meta charset="utf-8"> 
<style>
  .header_box {
     display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: center;
      background-color: #efefef;
      color: #000000;
      text-decoration: none;
      border: 1px solid #c9c5c5;
      border-radius: 5px;
      width:225px;
	    height:50px;
  }
  .header_boxx1 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:115px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .header_boxx2 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:140px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .header_boxx3 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:85px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .header_boxx4 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:120px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .header_boxx5 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:215px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .header_boxx6 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:135px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .blowheader_box{
    display: block;
      padding: 10px;
      font-size:18px;
      margin-right: 10px;
      text-align: center;
      background-color: #efefef;
      color: #000000;
      text-decoration: none;
      border: 1px solid #ffffff;
      border-radius: 5px;
      width:170px;
	    height:40px;
  }
  .box_style{
    background: #ffffff;
  }
  blockquote {
  margin: 0 0 0px;
  }
</style>
</head>
<p><br /></p>


<p class="header_boxx1" id="timeline">Timeline</p>
<div class="timeline">
  <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/18776253/" target="_blank" style="color:#520049">2008</a></h3>
    </div>
    <div class="body">
      <p>The aptamers were synthesized for the first time<sup>[<a href="#ref1" style="color:#520049">1</a>]</sup></p>
    </div>
  </div>
  <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/18258851/" target="_blank" style="color:#520049">2008</a></h3>
    </div>
    <div class="body">
      <p>Ccl2 blockade with mNOX-E36–3′PEG effectively blocks macrophage recruitment into the glomerular and interstitial compartments of the kidney<sup>[<a href="#ref2" style="color:#520049">2</a>]</sup></p>
    </div>
  </div>
  <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/19156777/" target="_blank" style="color:#520049">2009</a></h3>
    </div>
    <div class="body">
      <p>Ccl2 mediates the recruitment of glomerular and interstitial macrophages but this mechanism does not contribute to the progression of Alport nephropathy in Col4a3-deficient mice<sup>[<a href="#ref3" style="color:#520049">3</a>]</sup></p>
    </div>
  </div>
    <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/21813474/" target="_blank" style="color:#520049">2012</a></h3>
    </div>
    <div class="body">
      <p>Pharmacological inhibition of MCP-1 with mNOX-E36 was investigated<sup>[<a href="#ref4" style="color:#520049">4</a>]</sup></p>
    </div>
  </div>
  <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/24561613/" target="_blank" style="color:#520049">2014</a></h3>
    </div>
    <div class="body">
      <p>Inhibition of monocyte infiltration by targeting the chemokine CCL2 prevented fibrosis-associated angiogenesis, but not fibrosis progression<sup>[<a href="#ref5" style="color:#520049">5</a>]</sup></p>
    </div>
  </div>
  <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/24481979/" target="_blank" style="color:#520049">2014</a></h3>
    </div>
    <div class="body">
      <p>Pharmacological inhibition of Ly-6C(+) monocyte recruitment using the CCL2-inhibitor, mNOX-E36, accelerates regression from toxic and metabolic liver fibrosis<sup>[<a href="#ref6" style="color:#520049">6</a>]</sup></p>
    </div>
  </div>
  <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/25970072/" target="_blank" style="color:#520049">2015</a></h3>
    </div>
    <div class="body">
      <p>Spiegelmer-based inhibition of MCP-1/CCR2 with the compound mNOX-E36 results in moderate but statistically significant improvements for graft survival<sup>[<a href="#ref8" style="color:#520049">8</a>]</sup></p>
    </div>
  </div>
  <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/28186566/" target="_blank" style="color:#520049">2017</a></h3>
    </div>
    <div class="body">
      <p>Inhibition of the CCL2/CCL2 receptor axis with NOX-E36 was generally safe and well tolerated<sup>[<a href="#ref9" style="color:#520049">9</a>]</sup></p>
    </div>
  </div>
  <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/28837800/" target="_blank" style="color:#520049">2017</a></h3>
    </div>
    <div class="body">
      <p>CCL2 inhibition in diabetic nephropathy effectively reduces proteinuria and is associated with restoration of glomerular endothelial glycocalyx size<sup>[<a href="#ref10" style="color:#520049">10</a>]</sup></p>
    </div>
  </div>
</div>


         
<font ><p class="header_boxx2" id="description">Description</p></font>
<font >In 2014, Oberthuer, D and Achenbach, J chemically synthesized  NOX-E36 L-aptamer and the structure was solved applying single-wavelength anomalous diffraction (SAD) and reﬁned to 2.05 Å<sup>[<a href="#ref7" style="color:#520049">7</a></sup><sup>]</sup>.<br></font>
<p><br /></p> <br>

<p class="header_boxx3" id="SELEX">SELEX</p>
<p>In 2015, Dominik Oberthür and  John Achenbach firstly selected aptamers from oligonucleotide libraries to bind to the non-natural, mirror-image form of an intended target molecule by an evolutionary screening technique called SELEX. Then, they selected the aptamer sequence from non-natural L-nucleotides by chemical synthesis, an exact mirror image of the aptamer is produced, the Spiegelmer, which consequently binds to L-CCL2<sup>[<a href="#ref7" style="color:#520049">7</a>]</sup>.<br>
Detailed information are accessible on <a href="{{ site.url }}{{ site.baseurl }}/SELEX" target="_blank" style="color:#520049"><b><i>SELEX</i></b></a> page.</p>
<br> <br>    



<p class="header_boxx4" id="Structure">Structure</p>
<p class="blowheader_box">2D representation</p>
<font><p>Here we use ribodraw to complete the figure, through the 3D structure information<sup>[<a href="#ref7" style="color:#520049">7</a>]</sup>.</p></font>
<font><p>5'-GCACGUCCCUCACCGGUGCAAGUGAAGCCGAGGCUCUGCG-3'</p></font>
<img src="/images/2D/NOX-E36-aptamer_2D.svg" alt="drawing" style="width:800px;display:block;margin:0 auto;border-radius:0;" class="img-responsive">
<div style="display: flex; justify-content: center;">   
</div>
<br>


<p class="blowheader_box">3D visualisation</p>             
<font >Oberthuer, D and Achenbach, J. sovled the crystal structure, at 2.05 A resolution, of an RNA aptamer bound to L-CCL2 has been determined. The PDB ID of this structure is 4R8I<sup>[<a href="#ref7" style="color:#520049">7</a></sup><sup>]</sup>. Additional available structures that have been solved and detailed information are accessible on <a href="{{ site.url }}{{ site.baseurl }}/structures" target="_blank" style="color:#520049"><b><i>Structures</i></b></a> page.</font>
<div ><font ><p style="text-align:right;margin-bottom: 0px;">(Clicking the "Settings/Controls info" to turn Spin off)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p></font>
  <table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;"><tr>
  <td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/3D/NOX-E36-aptamer_3D1.svg" alt="drawing" style="width:500px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  <td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px">
  <html lang="en">
    <head>
      <meta charset="utf-8" />
      <meta name="viewport" content="width=device-width, user-scalable=no, minimum-scale=1.0, maximum-scale=1.0">
      <meta http-equiv="X-UA-Compatible" content="IE=edge">
      <title>PDBe Molstar</title>
      <!-- Molstar CSS & JS -->
      <link rel="stylesheet" type="text/css" href="https://www.ebi.ac.uk/pdbe/pdb-component-library/css/pdbe-molstar-1.2.1.css">
      <script src="/js/mol/ro_pdbe-molstar-plugin-1.2.1.js"></script>
        <style>
          * {
              margin: 0;
              padding: 0;
              box-sizing: border-box;
          }
          .msp-plugin ::-webkit-scrollbar-thumb {
              background-color: #474748  !important;
          }
          .viewerSection1 {
            padding-top: 0px;
          }
          .controlsSection1 {
            width: 300px;
              display: flex;
              float:left;
              padding: 0px 0 0 0;
              height:25px;
            }
            .controlBox1 {
              border: 0px solid lightgray;
              padding: 0px;
              margin-bottom: 0px;
            }
          #myViewer1{
            float:left;
            width:500px;
            height: 500px;
            position:relative;
          }
        </style>
    </head>
    <body onload="customize()">
        <div class="controlsSection1">
            <button onclick="
              var selectSections1 = [
                {
  struct_asym_id: 'A',    
  start_residue_number:3, 
  end_residue_number:70, 
  color:{r:128,g:219,b:158}
},
{
  struct_asym_id: 'B', 
  start_residue_number:1, 
  end_residue_number:40, 
  color:{r:255,g:135,b:10}
},
{
  struct_asym_id: 'B', 
  start_residue_number:5, 
  end_residue_number:5, 
  color:{r:255,g:0,b:255}
},
{
  struct_asym_id: 'B', 
  start_residue_number:9, 
  end_residue_number:11, 
  color:{r:255,g:0,b:255}
},
{
  struct_asym_id: 'B', 
  start_residue_number:22, 
  end_residue_number:22, 
  color:{r:255,g:0,b:255}
},
{
  struct_asym_id: 'B', 
  start_residue_number:24, 
  end_residue_number:24, 
  color:{r:255,g:0,b:255}
},
{
  struct_asym_id: 'B', 
  start_residue_number:26, 
  end_residue_number:27, 
  color:{r:255,g:0,b:255}
}
              ]
            viewerInstance1.visual.select({ data: selectSections1, nonSelectedColor: {r:255,g:255,b:255}})" style="float:right;height:25px;width: 120px;">Color Selection</button><br><br>
          <button button style="float: left;height:25px;width: 120px;" onclick="viewerInstance1.visual.clearSelection()">Clear Selection</button><br><br>
      </div>
    <div class="viewerSection1">
    <!-- Molstar container -->
      <div id="myViewer1"></div>
    </div>
    <script>
      var viewerInstance1 = new PDBeMolstarPlugin();
      var options1 = {
        customData:{
        url:'/pdbfiles/4r8i-3D.pdb',
        format: 'pdb'},
        expanded: false,
        hideControls: true,
        bgColor: {r:255, g:255, b:255},
        }
      var viewerContainer1 = document.getElementById('myViewer1');
      viewerInstance1.render(viewerContainer1, options1);
  window.addEventListener('load', function() {
    var colorSelectionButton1 = document.querySelector('.controlsSection1 button');
    colorSelectionButton1.click();
  });
</script>
</body>
</html></td>
</tr></table><br>
</div>


<p class="blowheader_box">Binding pocket</p>             
<font >Left: Surface representation of the binding pocket of the aptamer generated from PDB ID: 4R8I. L-CCL2 (shown in vacuumm electrostatics), blue is positive charge, red is negative charge. Right: The hydrogen bonds of binding sites of the aptamer bound with L-CCL2.</font>
<br><br>
  <table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;"><tr>
  <td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/Binding_pocket/NOX-E36-aptamer_binding_pocket1.svg" alt="drawing" style="width:500px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  <td style="text-align:center;padding-bottom: 0px;padding-right: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/Binding_pocket/NOX-E36-aptamer_binding_pocket2.svg" alt="drawing" style="width:500px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  </tr>
  </table>
  <br><br>





<font ><p class="header_boxx5" id="ligand-recognition">Ligand information</p></font>  
<p class="blowheader_box">SELEX ligand</p>
<font >Oberthuer, D and Achenbach, J investigated the ion dependence of L-aptamer binding using surface plasmon resonance (SPR), revealing a strong dependence on Ca2+ , which appears to be important for proper folding of the L-aptamer and will likely occupy the position of Sr2+ observed in the structure.  And they also studied the effect of the mutations on L-aptamer afffinity and measured the L-aptamer’s affinity using SPR<sup>[<a href="#ref7" style="color:#520049">7</a>]</sup>.</font >
<div style="display: flex; justify-content: center;">
<br>
<table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(0)">Name</th>
        <th onclick="sortTable(0)">Sequence</th>
        <th onclick="sortTable(0)">Ligand</th>
        <th onclick="sortTable(1)">Affinity</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td0">NOX-E36 L-aptamer</td>
        <td name="td1">5'-GCACGUCCCUCACCGGUGCAAGUGAAGCCGAGGCUCUGCG-3'</td>
        <td name="td3">L-CCL2</td>
        <td name="td4">1.40±0.16nM</td>
      </tr>
	  </tbody>
  </table>
  </div>
<br>

<p class="blowheader_box">Structure ligand</p>
<font><p>Acts as a ligand for C-C chemokine receptor CCR2. Signals through binding and activation of CCR2 and induces a strong chemotactic response and mobilization of intracellular calcium ions. Exhibits a chemotactic activity for monocytes and basophils but not neutrophils or eosinophils. May be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis.-----from uniprot</p></font>
<br>
<table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(0)">Uniprot ID</th>
        <th onclick="sortTable(1)">Pfam</th>
        <th onclick="sortTable(2)">MW</th>
        <th onclick="sortTable(3)">Amino acids sequences</th>
        <th onclick="sortTable(4)">PDB ID</th>
        <th onclick="sortTable(5)">GenBank</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td0"><a href="https://www.uniprot.org/uniprotkb/P13500/entry" target="_blank" style="color:#520049"><b>P13500</b></a></td>
        <td name="td1"><a href="https://www.ebi.ac.uk/interpro/protein/UniProt/P13500/" target="_blank" style="color:#520049"><b>P13500</b></a></td>
        <td name="td2">8.82 kDa</td>
        <td name="td3">MQPDAINAPVTCCYNFTNRKISVQRLASYRRITSSKCPKEAVIFKTIVAKEICADPKQKWVQDSMDHLDKQTQTPKT</td>
        <td name="td4"><a href="https://www.rcsb.org/structure/1DOK" target="_blank" style="color:#520049"><b>1DOK</b></a></td>
        <td name="td5"><a href="https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?lvl=0&id=9606" target="_blank" style="color:#520049"><b>9606</b> </a></td>
      </tr>
	  </tbody>
  </table>
 <table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;"><tr>
<td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px"><img src="/images/Structure_ligand/NOX-E36-aptamer_stru_ligand.svg" alt="drawing" style="width:800px"  px="" /></td>
</tr>
</table>
<div style="display: flex; justify-content: center;">
  </div>


<p class="blowheader_box">Similar compound</p>
<font><p>We used the Dail server website to compare the structural similarities of ligand proteins, and chose the top 10 in terms of similarity for presentation. The Dali server is a network service for comparing protein structures in 3D. Dali compares them against those in the Protein Data Bank (PDB). Z-score is a standard score that is converted from an original score. The list of neighbours is sorted by Z-score. Similarities with a Z-score lower than 2 are spurious. RMSD(Root Mean Square Deviation) value is used to measure the degree to which atoms deviate from the alignment position.</p></font>
<table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(1)">PDB</th>
        <th onclick="sortTable(2)">Z-score</th>
        <th onclick="sortTable(3)">RMSD</th>
        <th onclick="sortTable(4)">Description</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td1">7SO0-B</td>
        <td name="td2">12</td>
        <td name="td3">0.7</td>
        <td name="td4">Evasin p974</td>
      </tr>
      <tr>
        <td name="td1">2VXW-A</td>
        <td name="td2">12</td>
        <td name="td3">1.5</td>
        <td name="td4">C-C motif chemokine 5</td>
      </tr>
      <tr>
        <td name="td1">1NR4-E</td>
        <td name="td2">11.3</td>
        <td name="td3">1.5</td>
        <td name="td4">Thymus and activation-regulated chemokine</td>
      </tr>
      <tr>
        <td name="td1">5EKI-E</td>
        <td name="td2">10.4</td>
        <td name="td3">1.5</td>
        <td name="td4">C-C motif chemokine 21</td>
      </tr>
      <tr>
        <td name="td1">2JYO-A</td>
        <td name="td2">9.4</td>
        <td name="td3">2.1</td>
        <td name="td4">C-C motif chemokine 20 (small-inducible cytokine)</td>
      </tr>
      <tr>
        <td name="td1">1B2T-A</td>
        <td name="td2">8.7</td>
        <td name="td3">3.5</td>
        <td name="td4">Protein (fractalkine)</td>
      </tr>
      <tr>
        <td name="td1">2MP1-A</td>
        <td name="td2">8.3</td>
        <td name="td3">2.0</td>
        <td name="td4">C-C motif chemokine 19</td>
      </tr>
      <tr>
        <td name="td1">1O80-A</td>
        <td name="td2">7.9</td>
        <td name="td3">2.4</td>
        <td name="td4">Small inducible cytokine b10</td>
      </tr>
      <tr>
        <td name="td1">1F9P-A</td>
        <td name="td2">7.4</td>
        <td name="td3">1.6</td>
        <td name="td4">Connective tissue activating peptide-iii</td>
      </tr>
      <tr>
        <td name="td1">4HED-A</td>
        <td name="td2">6.8</td>
        <td name="td3">2.2</td>
        <td name="td4">Uncharacterized protein</td>
      </tr>
	  </tbody>
  </table>

<br><br>

                 
<p class="header_boxx6" id="references">References</p>
                
<a id="ref1"></a><font><strong>[1] Physicochemical stability of NOX-E36, a 40mer L-RNA (Spiegelmer) for therapeutic applications.</strong></font><br />
Maasch, C., Buchner, K., Eulberg, D., Vonhoff, S., & Klussmann, S.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/18776253/" target="_blank" style="color:#520049" >Nucleic acids symposium series, (52), 61–62. (2008)</a>
<br />
                
<a id="ref2"></a><font><strong>[2] Late onset of Ccl2 blockade with the Spiegelmer mNOX-E36-3'PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice.</strong></font><br />
Ninichuk, V., Clauss, S., Kulkarni, O., Schmid, H., Segerer, S., Radomska, E., Eulberg, D., Buchner, K., Selve, N., Klussmann, S., & Anders, H. J<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/18258851/" target="_blank" style="color:#520049">The American journal of pathology, 172(3), 628–637. (2008)</a>
<br />
                
<a id="ref3"></a><font><strong>[3] Ccl2/Mcp-1 blockade reduces glomerular and interstitial macrophages but does not ameliorate renal pathology in collagen4A3-deficient mice with autosomal recessive Alport nephropathy.</strong></font><br />
Clauss, S., Gross, O., Kulkarni, O., Avila-Ferrufino, A., Radomska, E., Segerer, S., Eulberg, D., Klussmann, S., & Anders, H. J.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/19156777/" target="_blank" style="color:#520049">The Journal of pathology, 218(1), 40–47. (2009)</a>
<br />
                
<a id="ref4"></a><font><strong>[4] Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.</strong></font><br />
Baeck, C., Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., Trautwein, C., & Tacke, F.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/21813474/" target="_blank" style="color:#520049">Gut,61(3), 416–426. (2012)</a>
<br />
                
<a id="ref5"></a><font><strong>[5] CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.</strong></font><br />
Ehling, J., Bartneck, M., Wei, X., Gremse, F., Fech, V., Möckel, D., Baeck, C., Hittatiya, K., Eulberg, D., Luedde, T., Kiessling, F., Trautwein, C., Lammers, T., & Tacke, F.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/24561613/" target="_blank" style="color:#520049">Gut,63(12), 1960–1971. (2014)</a>
<br />

<a id="ref6"></a><font><strong>[6] Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice.</strong></font><br />
Baeck, C., Wei, X., Bartneck, M., Fech, V., Heymann, F., Gassler, N., Hittatiya, K., Eulberg, D., Luedde, T., Trautwein, C., & Tacke, F.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/24481979/" target="_blank" style="color:#520049">Hepatology (Baltimore, Md.), 59(3), 1060–1072. (2014)</a>
<br />       

<a id="ref7"></a><font><strong>[7] Crystal structure of a mirror-image L-RNA aptamer (Spiegelmer) in complex with the natural L-protein target CCL2.</strong></font><br />
Oberthür D, Achenbach J, Gabdulkhakov A, Buchner K, Maasch C, Falke S, Rehders D, Klussmann S, Betzel C.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/25901662/" target="_blank" style="color:#520049">Nat Commun, 6:6923 (2015)</a>
<br />  

<a id="ref8"></a><font><strong>[8] Spiegelmer Inhibition of MCP-1/CCR2--Potential as an Adjunct Immunosuppressive Therapy in Transplantation.</strong></font><br />
Kalnins, A., Thomas, M. N., Andrassy, M., Müller, S., Wagner, A., Pratschke, S., Rentsch, M., Klussmann, S., Kauke, T., Angele, M. K., Bazhin, A. V., Fischereder, M., Werner, J., Guba, M., & Andrassy, J.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/25970072/" target="_blank" style="color:#520049">Scandinavian journal of immunology, 82(2), 102–109. (2015)</a>
<br />  

<a id="ref9"></a><font><strong>[9] C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria.</strong></font><br />
Menne, J., Eulberg, D., Beyer, D., Baumann, M., Saudek, F., Valkusz, Z., Więcek, A., Haller, H., & Emapticap Study Group<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/28186566/" target="_blank" style="color:#520049">Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 32(2), 307–315. (2017)</a>
<br />

<a id="ref10"></a><font><strong>[10] Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy.</strong></font><br />
Boels, M. G. S., Koudijs, A., Avramut, M. C., Sol, W. M. P. J., Wang, G., van Oeveren-Rietdijk, A. M., van Zonneveld, A. J., de Boer, H. C., van der Vlag, J., van Kooten, C., Eulberg, D., van den Berg, B. M., IJpelaar, D. H. T., & Rabelink, T. J.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/28837800/" target="_blank" style="color:#520049">The American journal of pathology, 187(11), 2430–2440. (2017)</a>
<br />  